Published in Curr Pain Headache Rep on October 01, 2012
Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study. J Headache Pain (2016) 0.87
Triptans in prevention of menstrual migraine: a systematic review with meta-analysis. J Headache Pain (2013) 0.80
Frovatriptan and rizatriptan economic EVAluation: the FREEVA study. J Headache Pain (2013) 0.77
Treatment of menstrual migraine; multidisciplinary or mono-disciplinary approach. J Headache Pain (2017) 0.75
'Ictal epileptic headache': recent concepts for new classifications criteria. Cephalalgia (2012) 3.19
Lifting the burden: the first 7 years. J Headache Pain (2010) 2.55
New policies to consolidate the journal's hold on its latest position. J Headache Pain (2009) 2.33
A tier-upon-tier march towards the impact factor. J Headache Pain (2008) 2.09
Artificial niche microarrays for probing single stem cell fate in high throughput. Nat Methods (2011) 2.03
While climbing the hill, you think it's possible. J Headache Pain (2009) 1.97
L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors. Proc Natl Acad Sci U S A (2013) 1.94
Headache disorders are third cause of disability worldwide. J Headache Pain (2015) 1.93
The Journal of Headache and Pain keeps gaining consensus. J Headache Pain (2010) 1.70
Psychiatric comorbidity in patients with chronic daily headache and migraine: a selective overview including personality traits and suicide risk. J Headache Pain (2009) 1.60
Refractory chronic migraine: a consensus statement on clinical definition from the European Headache Federation. J Headache Pain (2014) 1.53
The Global Campaign, World Health Organization and Lifting The Burden: collaboration in action. J Headache Pain (2011) 1.52
Fathoming the kynurenine pathway in migraine: why understanding the enzymatic cascades is still critically important. Intern Emerg Med (2015) 1.52
Rehabilitating chronic migraine complicated by medication overuse headaches: how can we prevent migraine relapse? Intern Emerg Med (2010) 1.49
Time to act on headache disorders. J Headache Pain (2011) 1.47
The definitive position of headache among the major public health challenges. An end to the slippery slope of disregard. J Headache Pain (2007) 1.40
Hemochromatosis-induced bipolar disorder: a case report. Gen Hosp Psychiatry (2011) 1.40
Neuromodulation of chronic headaches: position statement from the European Headache Federation. J Headache Pain (2013) 1.39
Chronic migraine plus medication overuse headache: two entities or not? J Headache Pain (2011) 1.39
Long-term benefits of botulinum toxin type A (BOTOX) in chronic daily headache: a five-year long experience. J Headache Pain (2006) 1.38
Psychiatric comorbidity and suicide risk in patients with chronic migraine. Neuropsychiatr Dis Treat (2010) 1.37
Headache and emergency medicine: sharing a language for a common project. Intern Emerg Med (2008) 1.36
Refractory chronic cluster headache: a consensus statement on clinical definition from the European Headache Federation. J Headache Pain (2014) 1.31
Psychometric properties of the stagnation scale in medication overuse headache patients. J Headache Pain (2015) 1.29
Effects of the antimicrobial peptide temporin L on cell morphology, membrane permeability and viability of Escherichia coli. Biochem J (2004) 1.22
A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine. J Headache Pain (2011) 1.22
Temporin L: antimicrobial, haemolytic and cytotoxic activities, and effects on membrane permeabilization in lipid vesicles. Biochem J (2002) 1.20
Framing education on headache disorders into the Global Burden of Disease Study 2010. The European Headache Federation stands ready. J Headache Pain (2013) 1.19
Chronicling the June conundrum. J Headache Pain (2011) 1.18
The Global Burden of Disease survey 2010, Lifting The Burden and thinking outside-the-box on headache disorders. J Headache Pain (2013) 1.17
A liquid chromatography/mass spectrometry method for the evaluation of intestinal permeability. Clin Biochem (2008) 1.12
Emerging treatment for chronic migraine and refractory chronic migraine. Expert Opin Emerg Drugs (2012) 1.10
A six year retrospective review of occipital nerve stimulation practice--controversies and challenges of an emerging technique for treating refractory headache syndromes. J Headache Pain (2013) 1.09
Framing comorbidities and co-occurrences in a migraine with aura patient. Intern Emerg Med (2014) 1.07
Temporins, small antimicrobial peptides with leishmanicidal activity. J Biol Chem (2004) 1.07
A synergism between temporins toward Gram-negative bacteria overcomes resistance imposed by the lipopolysaccharide protective layer. J Biol Chem (2006) 1.06
Prevalence and burden of primary headache in Akaki textile mill workers, Ethiopia. J Headache Pain (2008) 1.05
Headache medicine: academic teaching in Europe. The Sapienza University Master's Degree. Headache (2007) 1.05
Tumor necrosis factor gene polymorphism in migraine. Headache (2002) 1.04
A tasty cultural event. J Headache Pain (2012) 1.04
Microdrop printing of hydrogel bioinks into 3D tissue-like geometries. Adv Mater (2011) 1.03
New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: is gold all that glitters? J Headache Pain (2013) 1.02
Academic specialist education in headache medicine. Next move for the headache community. J Headache Pain (2005) 1.02
Chronic migraine: comorbidities, risk factors, and rehabilitation. Intern Emerg Med (2010) 1.02
Ictal epileptic headache: an old story with courses and appeals. J Headache Pain (2012) 1.02
Interactions of the antimicrobial peptides temporins with model biomembranes. Comparison of temporins B and L. Biochemistry (2002) 0.98
Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1. Mol Brain (2013) 0.96
Refractory headache: one term does not cover all--a statement of the European Headache Federation. J Headache Pain (2014) 0.95
Overattachment and perceived disability in chronic migraineurs. Clin Neurol Neurosurg (2012) 0.94
Urinary concentration of 8-isoprostane as marker of severity of pediatric OSAS. Sleep Breath (2014) 0.94
Improving care through health economics analyses: cost of illness and headache. J Headache Pain (2008) 0.93
Future drugs for migraine. Intern Emerg Med (2009) 0.93
Pharmacokinetic evaluation of almotriptan for the treatment of migraines. Expert Opin Drug Metab Toxicol (2013) 0.92
High-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification of carbamazepine, oxcarbazepine, and their main metabolites in human serum. Ther Drug Monit (2012) 0.92
Visualization of multiple catheters with electroanatomical mapping reduces X-ray exposure during atrial fibrillation ablation. Europace (2011) 0.91
Effect of natural L- to D-amino acid conversion on the organization, membrane binding, and biological function of the antimicrobial peptides bombinins H. Biochemistry (2006) 0.90
An amphibian antimicrobial peptide variant expressed in Nicotiana tabacum confers resistance to phytopathogens. Biochem J (2003) 0.89
Cardiac resynchronization therapy increases plasma levels of the endogenous inotrope apelin. Eur J Heart Fail (2006) 0.89
Mental turmoil, suicide risk, illness perception, and temperament, and their impact on quality of life in chronic daily headache. J Headache Pain (2008) 0.89
Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine. J Headache Pain (2010) 0.89
Patient outcome in migraine prophylaxis: the role of psychopharmacological agents. Patient Relat Outcome Meas (2010) 0.88
White matter hyperintensities and self-reported depression in a sample of patients with chronic headache. J Headache Pain (2012) 0.88
Improving quality in population surveys of headache prevalence, burden and cost: key methodological considerations. J Headache Pain (2013) 0.87
The validation of the Italian Perceived Disability Scale (IPDS) in chronic daily headache sufferers. J Headache Pain (2008) 0.87
Lenalidomide for aggressive B-cell lymphoma involving the central nervous system? Am J Hematol (2011) 0.87
Functional characterisation of the 1-18 fragment of esculentin-1b, an antimicrobial peptide from Rana esculenta. Peptides (2003) 0.87
Pharmacokinetic evaluation of frovatriptan. Expert Opin Drug Metab Toxicol (2011) 0.86
A case of oesophageal ulcer developed after taking homeopathic pill in a young woman. World J Gastroenterol (2007) 0.86
Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine. J Headache Pain (2010) 0.86
A liquid chromatography-tandem mass spectrometry method for the determination of 5-Fluorouracil degradation rate by intact peripheral blood mononuclear cells. Ther Drug Monit (2009) 0.85
Ranacyclins, a new family of short cyclic antimicrobial peptides: biological function, mode of action, and parameters involved in target specificity. Biochemistry (2003) 0.84
Sumatriptan succinate : pharmacokinetics of different formulations in clinical practice. Expert Opin Pharmacother (2012) 0.84
Update on Medication-Overuse Headache and Its Treatment. Curr Treat Options Neurol (2015) 0.84